Anil Vij was last month administered a trial dose of a coronavirus vaccine as part of the third phase trial of Bharat Biotech’s Covaxin.
Barely two weeks after being administered a trial vaccine shot of Bharat Biotech’s Covaxin, Haryana’s Health Minister Anil Vij Saturday tested positive of the novel coronavirus. The 67-year-old BJP veteran is diabetic, and had recently undergone a surgery for a thigh bone fracture. He had volunteered to participate in the vaccine’s human phase trials, in which over 25,000 persons were administered trial doses.
On November 20, Mr Vij, who is also Haryana’s Health Minister, participated in the third phase trial of Bharat Biotech’s Covaxin. He had earlier announced on Twitter that he will be the first volunteer in his state for the vaccine trials.
After getting Covaxin’s trial shot for Covid-19, Vij had said: “It is a matter of pride for every Indian that Bharat Biotech is coming up with an indigenous vaccine for COVID-19. I had volunteered to become one of the participant for the third phase so that people shed their fears and come forward to volunteer. With this, the entire process of developing the vaccine shall be expedited.
Health minister’s statements have created conflict toward vaccine safety, efficacy because trial has to be confidential. Vij participated in a double-blind trial which means the investigators, the participants and the company are not aware of who is assigned to which group. If Vij received the placebo, then he would not have had any protection against the virus to begin with. However, if he received the vaccine, his subsequently contracting COVID-19 needs to be seen against factors such as the trial-dose-regimen and vaccine efficacy.